Clinical Trial Update: Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial update for F-627 in women with breast cancer undergoing myelotoxic chemotherapy; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neutropenia

Drugs mentioned

• F-627

Snippet

Sponsor: EVIVE Biotechnology | Conditions: Breast Cancer, Neutropenia | Phase 3 | Status: COMPLETED | Results posted: 2019-03-26